Home » Stocks » Sensus Healthcare

Sensus Healthcare, Inc. (SRTS)

Stock Price: $2.88 USD -0.18 (-5.88%)
Updated Aug 6, 2020 4:00 PM EDT - Market closed
After-hours: $2.85 -0.03 (-1.04%) Aug 6, 5:57 PM

Stock Price Chart

Key Info

Market Cap 47.56M
Revenue (ttm) 23.51M
Net Income (ttm) -3.17M
Shares Out 16.52M
EPS (ttm) -0.19
PE Ratio n/a
Forward PE 51.55
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 6, 2020
Last Price $2.88
Previous Close $3.06
Change ($) -0.18
Change (%) -5.88%
Day's Open 3.06
Day's Range 2.88 - 3.11
Day's Volume 20,037
52-Week Range 1.76 - 6.58

More Stats

Market Cap 47.56M
Enterprise Value 33.02M
Earnings Date (est) Aug 6, 2020
Ex-Dividend Date n/a
Shares Outstanding 16.52M
Float 11.42M
EPS (basic) -0.18
EPS (diluted) -0.19
FCF / Share 0.30
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield 10.34%
Payout Ratio n/a
Shares Short 151,186
Short Ratio 7.21
Short % of Float 1.23%
Beta 0.24
PE Ratio n/a
Forward PE 51.55
P/FCF Ratio 9.67
PS Ratio 2.02
PB Ratio 1.98
Revenue 23.51M
Operating Income -3.41M
Net Income -3.17M
Free Cash Flow 4.92M
Net Cash 14.54M
Net Cash / Share 0.88
Gross Margin 74.69%
Operating Margin -14.52%
Profit Margin -13.50%
FCF Margin 20.92%
ROA -6.46%
ROE -12.23%
ROIC -15.50%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (6)

Buy 5
Overweight 0
Hold 1
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

(68.06% upside)
Current: $2.88
Target: 4.84
*Average 12-month price target from 6 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Revenue Growth3.16%28.36%39%44.17%76.81%-44.55%-
Gross Profit17.5616.9113.809.856.583.766.88
Operating Income-1.97-2.01-3.72-0.36-0.22-3.680.13
Net Income-1.70-2.02-3.71-0.35-0.24-3.700.11
Shares Outstanding16.2314.1213.2412.039.8940.8440.48
Earnings Per Share-0.10-0.14-0.28-0.03-0.08-103.76-10.02
Operating Cash Flow-2.11-8.56-3.06-0.85-1.34-1.87-0.13
Capital Expenditures-0.40-0.85-0.29-0.29-0.20-0.12-0.25
Free Cash Flow-2.51-9.42-3.34-1.14-1.54-1.99-0.38
Cash & Equivalents15.5915.4011.2111.535.094.560.00
Total Debt1.43-2.21-0.420.38-
Net Cash / Debt14.1715.409.0011.534.674.190.00
Book Value28.0026.4611.6815.275.924.14-
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Sensus Healthcare, Inc.
Country United States
Employees 53
CEO Joseph C. Sardano

Stock Information

Ticker Symbol SRTS
Stock Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Unique Identifier NASDAQ: SRTS
IPO Date June 3, 2016


Sensus Healthcare, Inc. manufactures, distributes, and markets superficial radiation therapy devices to healthcare providers worldwide. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates the embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sculptura product, a proprietary robotic intraoperative radiation therapy system that uses patented Beam Sculpting capabilities to treat various cancers during surgery; and Sentinel service program, which offers its customers protection for their systems. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons, eye shields, and disposable applicator tips, which are used to treat various sized lesions and various areas of the body. Sensus Healthcare, Inc. was founded in 2010 and is headquartered in Boca Raton, Florida.